Transvenous lead extraction of implantable cardioverter-defibrillators: A comprehensive outcome-and risk factor analysis.
Da-Un ChungHeiko BurgerLukas KaiserBrigitte OsswaldVolker BärschHerbert NägeleMichael KnautHermann ReichenspurnerNele GesslerStephan WillemsChristian ButterSimon PechaSamer Hakminull nullPublished in: Pacing and clinical electrophysiology : PACE (2023)
TLE is safe and efficacious in patients with 1- and 2-chamber ICD. Although lead dysfunction is the leading indication for extraction, systemic device-related infection is the main driver of all-cause mortality for ICD patients undergoing TLE.